Loading....
The Reagan-Udall Foundation for the FDA is holding a hybrid public workshop entitled “Qualifying Biomarkers to Support Rare Disease Regulatory Pathways.” This hybrid public workshop will explore primary disease activity biomarkers in rare genetic diseases using heparan sulfate in neuronopathic mucopolysaccharidoses (MPSs) as a case study for a biomarker to support accelerated approval.
Reagan-Udall Foundation for the FDA Rooftop
1333 New Hampshire Ave., NW
Washington, DC 20036
A confirmation email will be sent. Zoom webinar details are below.
Zoom Webinar Information (add this information to your calendar)
Please click the link below to join the webinar:
https://us06web.zoom.us/s/83532262176?pwd=KARCTsA9x3mtSE5B7sY5tH5EQB4d7p.1
Passcode: 228679
Or One tap mobile :
+13017158592,,83532262176#,,,,*228679# US (Washington DC)
+16469313860,,83532262176#,,,,*228679# US
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
+1 301 715 8592 US (Washington DC)
+1 312 626 6799 US (Chicago)
+1 646 558 8656 US (New York)
+1 346 248 7799 US (Houston)
+1 720 707 2699 US (Denver)
+1 253 215 8782 US (Tacoma)
Webinar ID: 835 3226 2176
Passcode: 228679
International numbers available: https://us06web.zoom.us/u/kbIsOjVpVU